Article Details
Retrieved on: 2022-02-10 12:51:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... $140 million in a Series C financing round less than two years after launching to develop therapies aimed at diseases of the innate immune system.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here